Company Filing History:
1 out of 495 
1 out of 258 Years Active: 2022
Title: Rashida Williams: Innovator in Cancer Research
Introduction
Rashida Williams is a prominent inventor based in Mississauga, Canada. She has made significant contributions to the field of cancer research through her innovative work on CD133-binding agents. Her research focuses on the detection and quantification of CD133-expressing cells, which play a crucial role in cancer progression.
Latest Patents
Rashida holds one patent titled "CD133-binding agents and uses thereof." This patent discloses novel CD133-binding agents that can be utilized for various applications, including detecting CD133-expressing cells, targeting these cells, and decreasing CD133 levels in them. The implications of her work are significant for the treatment and prevention of cancer.
Career Highlights
Throughout her career, Rashida has worked with esteemed institutions such as the University of Toronto and McMaster University. Her research has garnered attention for its potential to advance cancer therapies and improve patient outcomes.
Collaborations
Rashida has collaborated with notable colleagues, including Jason Moffat and Jarrett Adams. These partnerships have enriched her research and contributed to the development of her innovative ideas.
Conclusion
Rashida Williams is a trailblazer in the field of cancer research, with her patent on CD133-binding agents showcasing her commitment to advancing medical science. Her work has the potential to make a lasting impact on cancer treatment and detection.